AstraZeneca Invites Global Health Innovation Ecosystem Partners to the 6th China Ecosystem Conference Under the Theme of 'Harmony and Coexistence'

Today, the world is undergoing profound changes that are not confined to any specific moment, event, country, or region. The deepening trend of globalization and the persistent spread of uncertainties in the international economy, among other factors, all indicate that humanity has become a community with a shared future, where all members share weal and woe.

The concept of a Community with a Shared Future for Mankind emphasizes pluralistic coexistence. Given the world’s inherent diversity, achieving advanced development requires adhering to the philosophy of “harmonious coexistence,” respecting differences, and allowing diverse entities and perspectives to complement one another, ultimately realizing mutual coexistence and symbiosis.

In the economic landscape, “harmonious coexistence” emphasizes collaboration with ecosystem partners, resource sharing, achieving mutual benefits through harmony, and coordinated development. This is also the philosophy underpinning AstraZeneca’s establishment of a health innovation ecosystem.May 19, 2023,withThe 6th, Themed “Harmony and Coexistence”AstraZeneca China Ecosystem Conference & AstraZeneca China 30th Anniversary CelebrationIt will be held in Wuxi, located on the shores of Lake Tai.

This conference will center on implementing the strategic plan of “Healthy China 2030,” aligning with the key priorities in healthcare outlined during the “Two Sessions,” to advance new drug development and expand and decentralize high-quality medical resources. By collaborating with ecosystem partners across government, industry, academia, research, healthcare, and investment sectors, we will jointly promote high-quality development in the healthcare field.

Only through collaborative symbiosis in medical innovation can the entire industry achieve higher-dimensional development. To enhance integration with China’s healthcare industry, AstraZeneca aims to leverage the Ecosystem Conference as a bridge to establish a cross-sector platform for exchange and collaboration among government, academia, research institutions, enterprises, healthcare providers, and investors. This initiative seeks to support the nationwide rollout of more innovative achievements and benefit people worldwide. For partners in the health innovation ecosystem,AstraZeneca China Ecosystem Conference is an international event not to be missed:

First, in terms of conference stature, AstraZeneca has participated as a key strategic partner in the "Taihu Bay Life and Health Future Conference" for three consecutive years. Proposed and initiated by the Wuxi Municipal People's Government, the "Taihu Bay Life and Health Future Conference" is jointly organized with AstraZeneca and other strategic partners, aiming to accelerate the development of the life and health industry in the Yangtze River Delta region and across China.

In 2023, the “6th AstraZeneca China Ecosystem Conference,” themed “Harmony and Coexistence,” was also held as a flagship event during this period.

Secondly,ConferenceCovering guests from six major sectors: government, industry, academia, research, healthcare, and investment.To provide healthcare professionals with an opportunity for face-to-face interaction with top industry experts.The conference invites experts from different fieldsIndustry leaders discuss hot topics on the integration of the medical ecosystem and industrial symbiosis,toAttracting thousands of participants from both domestic and international life sciences and health sectorsTop Industry Experts and Leaders, High-Growth Companies, Technology Specialists, and Professional Investorsand other industry partners to participate.

• Partially Confirmed Attendees:

In terms of conference richness, the event adopted a “1+1+3+4+2+1+1” structure, comprising 1 main summit, 1 high-level forum on the metabolic industry, 3 thematic forums, 4 thematic closed-door meetings, 2 international cooperation forums, 1 dedicated signing session, and 1 ecosystem gala dinner celebrating the 30th anniversary.Maximize the richness of topic discussions.

Morning Session,Ecosystem Conference & AstraZeneca China 30th Anniversary Celebration Main Summit: A Premier Platform Showcasing the Breadth and Depth of Industry ThinkingLeading industry experts will engage in forward-looking, insightful, and authoritative dialogues on hot topics such as the high-quality development of the innovative ecosystem in healthcare, deep collaboration among government, academia, research institutions, hospitals, and investors in focused therapeutic areas, and digital health. The latest achievements of AstraZeneca’s health innovation ecosystem will also be shared with the industry at the Main Summit.

Afternoon Session,AstraZeneca FocusMetabolic Diseases, Chronic Cough and Asthma, Oncology, Primary Healthcare, and Digital Medical Marketingand other trending topics, through four formats: industrial high-level summits, thematic forums, closed-door thematic meetings, and international cooperation forums, to deepen and broaden the discussion on frontier issues, thereby meeting the needs for articulating capital investment logic, expressing the demands of innovative enterprises, and sensing industry trends.

Summit Forum on the Metabolic Industry:

Based on the agenda of the inaugural Metabolic Industry Summit, AstraZeneca’s intent to focus on and deepen its expertise in vertical therapeutic areas has become increasingly evident. At this summit, AstraZeneca joined forces with leaders in the healthcare sector, innovative companies, technical experts, and professional investors to collectivelyDiscussionIntegration of Medical and Enterprise Development in Metabolic Diseases, Drug R&D, Foods for Special Medical Purposes (FSMP), and Digital Therapeuticsand other cutting-edge topics. From Wuxi’s industrial policies and the development journey of the MMC (Metabolic Management Center) to new glucose-lowering drugs and trends in diabetes treatment, we will provide an in-depth analysis of comprehensive therapeutic strategies for metabolic diseases. We look forward to your participation in jointly promoting high-quality development in the healthcare sector!

Forum on Digital Intelligence in Healthcare:

This forum will begin withDigital Medical Communication, Digital Health Education, and the Digital-Intelligent Transformation of Healthcare EnterprisesProviding in-depth, multi-perspective analysis of the impact of digitalization on the healthcare industry. Experts from leading organizations such as Medlive, the China Anti-Cancer Association, and Sina Aiwen Doctor/Sina Health will share their profound insights. We have also invited industry giants including Huawei, Sanofi, and DXY to jointly discuss the practices and challenges of digitalization in the healthcare sector.

Forum on Innovative Integrated Management for the Diagnosis and Treatment of Chronic Cough and Asthma:

At this sub-forum, the conference will bring together experts to delve intoDiscussionIntegrated Innovative Management of Cough and Asthma in Chronic Diseases, Application of Impulse Oscillometry in Clinical Diagnosis, and the Role of Inflammation Assessment in Chronic Respiratory DiseasesFurthermore, we will share management experience in operating pulmonary function laboratories and implementing specialized cough-and-asthma care models in community hospitals, while discussing standardized diagnosis and treatment within medical consortia and strategies for optimizing pulmonary function testing facilities. Our goal is to improve the outpatient care journey for patients with cough and asthma, and to promote innovative payment models in healthcare. We look forward to your participation!

Themed Forum on Primary Care Chronic Disease Management:

Themed Forum on Primary Care Chronic Disease Management, which will explore the future development of chronic disease management at the primary care level, such asPromote the “Thousand Counties Project” and region-wide smart chronic disease management, as well as the application of big data and artificial intelligence in public health work. Next, we will delve intoDiscussion on the County-Level Chronic Disease Center under the Medical Community Model, Sharing Experiences of County-Level Chronic Disease Management Centers, and hold a roundtable discussion. Finally, we will exploreImplementation Pathways for Integrated Management of Smart Communities, and review our discussions and outcomes in the summary. We look forward to your participation in jointly advancing the intelligent transformation of chronic disease management at the primary care level!

Two Special Forums on Cooperation and Exchange:

As the pace of global economic integration accelerates, demand for and attention to global biopharmaceutical technology enterprises continue to grow. On the occasion of the 6th AstraZeneca China Ecosystem Conference in 2023, AstraZeneca’s International Life Sciences Innovation Park (iCampus) hosted two specialized exchange events to build a collaboration platform across different regions.

One session is dedicated to Russia, providing an in-depth analysis of the Russian biopharmaceutical market and strategies for overcoming international barriers. Key agenda items include: the current status and future development trends of Russia’s biopharmaceutical industry; technological innovations and collaboration opportunities in areas such as oncology treatment protocols, AI-driven diagnostics, and 5G-enabled medical applications; and interactions between Chinese and renowned Russian enterprises and institutions to facilitate connections with potential partners.

The second session is dedicated to Hong Kong, China, showcasing the appeal of its biopharmaceutical market and strengthening collaboration between the mainland and Hong Kong. Key agenda items include an analysis of the current state, policy environment, and investment opportunities in Hong Kong’s biopharmaceutical industry; a presentation on the development vision, positioning, and collaborative potential of the Hong Kong-Shenzhen Innovation and Technology Park; in-depth discussions with the park’s leadership to explore partnership opportunities; and rich interactive segments designed to provide attendees with a high-quality networking experience.

It is worth noting that 2023 also marks the 30th anniversary of AstraZeneca’s entry into China. Rooted in Wuxi, these three decades have been a journey of remarkable achievements. The “Ecosystem Summit & AstraZeneca China 30th Anniversary Gala Dinner” held at the conference will unveil a panoramic view of AstraZeneca China’s “Dynamic 30 Years.”

By establishing a dedicated forum on international cooperation, this conference aims to build a global partnership platform and facilitate the “going global” and “bringing in” of innovative models and enterprises.

Finally, healthcare professionals have the opportunity to directly connect with resources within AstraZeneca’s innovative health ecosystem.In addition to the aforementioned forums, AstraZeneca has also established dedicated off-site interactive zones to showcase outstanding cases of innovative collaborations and innovative solutions. Furthermore, it has set up negotiation areas for the implementation of innovative solutions and partnership recruitment zones to facilitate deep resource integration.

In 2017, AstraZeneca began building a health innovation ecosystem and has held an annual Ecosystem Conference in Wuxi, bringing together stakeholders from government, industry, academia, research, healthcare, and investment sectors to empower the health innovation ecosystem and explore pathways for whole-industry-chain development. Over the past six years, AstraZeneca, together with cross-sector partners, has accumulated substantial experience and achieved significant milestones in business innovation, multi-stakeholder collaborative innovation ecosystems, and digital transformation.

Taking the 5th AstraZeneca China Ecosystem Conference in 2022 as an example, leveraging the platform of the Taihu Bay Conference, AstraZeneca made significant collaborative strides in enhancing access to innovative drugs and therapies, digital applications, innovative payment solutions, exploration of industrial ecosystems, and extending benefits to primary healthcare institutions.

At the event, Wuxi High-Tech Zone, AstraZeneca, and ZhiZhong Medical officially launched the Metabolic Campus (MCampus). Building upon the National Standardized Management Center for Metabolic Diseases (MMC) model, this initiative has evolved into an innovation hub focused on the metabolic sector’s vertical domain. By introducing diverse partners, it aims to establish a full-industry-chain model spanning from basic research and translational medicine to industrialization. At the 6th AstraZeneca China Ecosystem Conference, we can also look forward to the latest developments in MMC and MCampus.

In the current international landscape, China has transitioned from being a unilateral recipient of new information to a parallel contributor. The international platform that AstraZeneca aims to build is designed to facilitate greater global collaboration, not only by encouraging foreign enterprises to enter the Chinese market but also by assisting Chinese companies in expanding overseas.Welcome to scan the QR code below,Follow the official WeChat account [International Life Science Innovation Park], click the registration link, and select “I Want to Attend.”Join the 6th AstraZeneca China Ecosystem Conference and the Celebration of AstraZeneca’s 30th Anniversary in China. May 19, Taihu Bay, Wuxi. See you there!